Publication | Open Access

AKT Hyperactivation and the Potential of AKT-Targeted Therapy in Diffuse Large B-Cell Lymphoma

Hematological MalignancyLymphoid NeoplasiaMedicineMalignant Blood DisorderImmunologyPathologyImmune Checkpoint InhibitorAkt HyperactivationAkt-targeted TherapyAdult T-cell Leukemia-lymphomaImmunotherapyOncologyCancer ResearchTumor Biology